ArticleJournal of clinical microbiology2014

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.

Paschalis Vergidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.